Nervobion

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nervobion

Property Description
Active Ingredients Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), Cyanocobalamin (Vitamin B12)
Form Oral Tablet (Coated), Solution for Injection (Ampoules)
Pharmacological Class Neurotropic Vitamin Medication
General Purpose Correcting B-vitamin deficiencies, supporting nerve function
Origin Derived (Synthetic forms of essential nutrients)

What Type of Medicine is Nervobion?

Nervobion is a well-recognized brand name for a pharmaceutical product classified as a Neurotropic Vitamin Medication, consistently ranked within the broader pharmacological group of B-Complex Vitamin Combinations. This preparation is defined by its specific, high-concentration Triple Combination of three essential water-soluble B vitamins: Thiamine (B1), Pyridoxine (B6), and Cyanocobalamin (B12). The specific selection of these three vitamins is clinically recognized for their direct and synergistic action on the nervous system. The product is available both as an Oral Tablet and as a Solution for Injection supplied in ampoules, the latter permitting rapid intramuscular administration when immediate systemic availability is required.


Composition and General Purpose

The medication's composition features the three neurotropic vitamins supplied as their stable salts, such as Thiamine Hydrochloride and Pyridoxine Hydrochloride. Nervobion is frequently positioned to address the underlying cause of neurological symptoms related to B-vitamin deficits. Its use is primarily directed toward situations where a nutritional deficiency of this specific combination of vitamins is suspected or confirmed. Pharmacological studies support that this combination provides the necessary cofactors for crucial metabolic processes within nerve cells. The product's overall purpose is to supply these nutrients to maintain the health, structural integrity, and normal nerve function of the nervous system.

What side effects are possible with Nervobion?

Possible side effects and safety information

The safety profile of this neurotropic vitamin combination (Thiamine, Pyridoxine, and Cyanocobalamin) is defined by official regulatory documents, detailing potential adverse reactions classified primarily by frequency and organ system.

Officially Documented Adverse Reactions

Adverse reactions are grouped by the systems they affect. Gastrointestinal Disorders such as nausea, vomiting, diarrhoea, and abdominal pain have been reported in post-marketing surveillance. Effects on the Skin and Subcutaneous Tissue include itching, rash, urticaria (hives), and an eczematous skin alteration. These effects are often classified with a Not Known frequency, meaning they are reported spontaneously but a reliable occurrence rate cannot be calculated.

More serious events are classified as Very Rare and involve the Immune System, including severe hypersensitivity reactions such as excessive sweating, tachycardia, and the potential for anaphylactic shock.

Serious Safety Constraints and Neurological Risk

Regulatory warnings explicitly highlight a risk of severe peripheral neuropathies. This risk is specifically linked to the long-term intake (typically six to twelve months) of high daily dosages of the Vitamin B6 component (>50 mg). Neuropathies may manifest as paresthesia or sensitivity disorders.

Furthermore, the combination must not be used before a Vitamin B12 deficiency diagnosis is established, as the formulation may mask the neurological symptoms of subacute degeneration of the spinal cord. High doses of Vitamin B6 are also noted to reduce the efficacy of Levodopa.

Population-Specific Constraints

Safety documents list restrictions for certain patient groups. The injectable solution is contraindicated for children below 14 years due to the high dosage of the active ingredients. The product's use is also restricted in patients with severe cardiac conduction disorders or acute decompensated cardiac failure, and its safety has not been established during pregnancy or lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose information for Nervobion focuses primarily on the potential risks associated with chronic, excessive intake of its Pyridoxine (Vitamin B6) component, as documented in government regulatory sources.

Overdose Domain Regulatory Description
Documented Manifestations The primary presentation is Peripheral Sensory Neuropathy, characterized by paresthesia (tingling, burning), numbness in extremities, ataxia (loss of coordination), and sensory gait disturbance.
Severe Outcomes Chronic overdose carries the mandated risk of severe persistent peripheral neuropathy and potential irreversible nerve damage (sensory neuronopathy) to the nervous system.

Required Emergency Actions

The onset of any neurological symptoms associated with toxicity, such as tingling, numbness, or difficulty with coordination, requires an immediate and explicit response as directed by regulatory authorities.

When to Seek Immediate Medical Help:

Regulatory guidance mandates that the product must be immediately discontinued. Urgent medical attention must be sought without delay upon the manifestation of any signs of neurological toxicity or sensory changes.

Overdose Management:

Official documents state that no specific pharmacological antidote is known for Pyridoxine toxicity. Treatment, therefore, involves strict cessation of the medication and providing comprehensive symptomatic and supportive therapy. In cases of confirmed acute overdosage, certain procedures like gastric lavage may be considered as supportive measures.

Therapeutic Uses of Nervobion

What Nervobion Treats: Main Uses and Benefits

Nervobion is a combination of B vitamins that assists with symptoms related to heightened physiological activity. This formulation is applied across domains where additional symptomatic support is needed, primarily focusing on conditions involving the nervous system and symptoms related to physical discomfort.

The combination is commonly used for the prevention and treatment of vitamin deficiencies, and is relevant in clinical settings that involve acute or unstable symptom patterns. The combination is applied within therapeutic domains involving vitamin deficiencies and conditions marked by increased discomfort or tension.

It is relevant for easing symptom clusters that may become intense or disruptive, especially symptoms of increased neurological or muscular activity. The medication may be part of symptomatic management for conditions presenting with systemic or localized discomfort and is often used during phases when symptoms become more noticeable. In situations where patients experience deficiency, the medication supports the patient during difficult episodes by easing distress.

“It supports the patient during difficult episodes by easing distress.”

Quick Fact: Support for Symptomatic Discomfort

Regulatory References

  1. Official Product Characteristics for Neurobion

Eligibility and Restrictions for Use

The eligibility for using Nervobion, a combination of Vitamins B1, B6, and B12, is strictly defined by regulatory documents, focusing on patient populations that are formally restricted or contraindicated.

Eligibility Scope

Population Status Regulatory Rule (Official Labeling)
Allowed Use Primarily indicated for Adults with a confirmed deficiency in Vitamins B1, B6, and/or B12.
Contraindicated Prohibited in patients with hypersensitivity to any component or who are undergoing Levodopa therapy.
Restricted Not recommended for children and adolescents (typically under 14 or 18 years) due to the high concentration of active ingredients.
Conditional Use Must not be given for Vitamin B12 deficiency before a diagnosis is established, as this may mask neurological symptoms of subacute degeneration of the spinal cord.

Special Population Restrictions

Age/Physiological State Official Eligibility Status
Pregnancy/Lactation Safety of high-dose use is not established. High doses of Vitamin B6 may inhibit breast milk production, requiring mothers on certain formulations to not breastfeed.
Comorbidity Focus Caution is advised for patients with impaired renal function who receive injection formulations. Regular monitoring is required for individuals on long-term therapy (e.g., over 6–12 months) due to the risk of peripheral sensory neuropathy from high cumulative Vitamin B6 intake.

Official eligibility statements strictly define the appropriate patient group as Adults without documented contraindications, and these rules serve to protect populations at risk from high-concentration vitamin formulations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific constraints for the co-administration of Nervobion’s active components (Thiamine, Pyridoxine, Cyanocobalamin) with certain medicinal products and substances.

A formal restriction exists for Levodopa monotherapy, which should not be co-administered, as the Pyridoxine ( B6) component is documented to rapidly metabolize Levodopa, resulting in a loss of its therapeutic effect.

Several agents are noted to affect the exposure of Nervobion's components. Pyridoxine Antagonists (e.g., Isoniazide, Cycloserine) and Oral Contraceptives are cited as decreasing the efficacy or serum concentration of B6 or B12. The long-term use of Loop Diuretics (e.g., Furosemide) is officially documented to accelerate the elimination and decrease the serum levels of Thiamine ( B1). Similarly, long-term use of Acid-Lowering Agents may lead to B12 deficiency due to reduced absorption.

Conversely, the product may result in the potentiation of the effect of co-administered Analgesics and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Furthermore, a specific constraint is documented for high doses of Pyridoxine (greater than 200 mg/ day), which is associated with a reduction in the therapeutic concentration of antiepileptic medications like Phenytoin and Phenobarbital. For oral forms, regulatory labels require separation of dosing from oral tetracycline-class antibiotics.

This profile is structured around the metabolic antagonism of B6 and the risk of decreased B-vitamin exposure, defining clinically significant constraints for co-administration.

Mechanism of Action

Nervobion supplies essential B-vitamins (B1, B6, B12) which function as coenzymes in neuronal carbohydrate, amino acid, and lipid metabolism.

Vitamin B1 (Thiamine) serves as the cofactor Thiamine Pyrophosphate (TPP), which is crucial for the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase reactions in the Krebs cycle, generating ATP for axonal transport.

Vitamin B6 (Pyridoxine) is converted to Pyridoxal-5-Phosphate (PLP), a coenzyme for over 100 enzymes, including those involved in neurotransmitter synthesis (e.g., GABA, dopamine, serotonin) and the conversion of homocysteine to cysteine.

Vitamin B12 (Cobalamin) functions as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase. The former is critical for myelin sheath maintenance by supplying methyl groups necessary for phospholipid synthesis in the nervous system.

Dosage and Administration Information

The use and administration of Nervobion (a combination of B vitamins B1, B6, and B12) must strictly follow the prescription and advice of a healthcare professional.

General Administration Guidelines

Nervobion is available in various forms, including oral tablets and injectable solutions. The correct form, dosage, and duration of treatment depend on the specific medical condition being addressed, its severity, and the patient’s response.

  • Oral Tablets: Tablets should be swallowed whole with a small amount of water. They must not be crushed or chewed. Nervobion tablets are generally recommended to be taken with or immediately after a meal to aid absorption and minimize potential gastrointestinal discomfort.
  • Injections: The injectable solution is typically administered by a healthcare professional via deep intramuscular injection (I.M.), often into the gluteal muscle. Intravenous (I.V.) injection is generally advised against due to the risk of cardiovascular adverse effects, but when necessary, it should be done cautiously under strict medical supervision and is often combined with a glucose solution.

Dosage Considerations

The dosage for Nervobion can vary significantly based on the formulation and the patient’s needs. For severe cases, a higher initial dose, such as one injection daily, may be prescribed until acute symptoms subside. For milder cases or for maintenance, the dosage may be reduced to one injection two to three times weekly or switched to the oral form, typically one tablet taken up to three times a day.

Condition Type Typical Dosage Form Administration Frequency
Severe Cases (Initial) Injection (I.M.) Once daily
Mild Cases or Maintenance Oral Tablet One tablet, 1–3 times a day

It is crucial to monitor for any signs of adverse effects, such as peripheral sensory neuropathy (numbness or tingling), which has been linked to long-term intake (over 6–12 months) of high doses of Vitamin B6 (pyridoxine). Patients should never self-adjust the prescribed dosage or discontinue the medication without consulting their doctor.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nervobion


Evidence for use in Peripheral Neuropathy

Research involving Nervobion for Peripheral Neuropathy includes short-term randomized controlled trials (RCTs). These studies monitored outcomes related to symptom patterns and daily functioning. Researchers examined outcomes reflecting daily functioning or activity level and patient-reported outcomes describing perceived discomfort. The populations in these studies typically included adults experiencing symptoms of mild to moderate severity related to physical discomfort.

Studies observed patterns in outcomes related to physical discomfort over defined, relatively short time intervals. Data indicate patterns related to physical discomfort that were observed in the studies. This research adds to the evidence regarding how patients reported their experience when Nervobion was studied.

However, research remains limited. Long-term effects are not fully established, as follow-up durations were limited across the studies that were observed. Evidence quality varies across studies, and sample sizes were modest.


Evidence for use in Deficiency States

Nervobion was evaluated in studies exploring specific nutritional deficiency states characterized by functional limitations. Research examined temporary physiological imbalance, using observational cohorts and limited short-term trials. The studies focused on episodes where symptoms become more noticeable. Outcomes related to systemic or functional imbalance were the primary focus.

Research describes the changes that were monitored during the study period, particularly in laboratory values reflecting nutritional status. Studies report the patterns observed in systemic balance in the studied populations. Evidence describes symptom patterns associated with the deficiency states. Findings were mixed regarding specific markers in some reports.


What is Still Uncertain About Nervobion

Certainty remains low due to the limited scope of the findings; results apply only to the populations studied. Research provides context but not individual predictions. There is limited information for long-term outcomes, and the comparative evidence is lacking. Data for certain groups (such as children or pregnant individuals) remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Nervobion (FAQ)


Q: Why is Nervobion often mentioned in connection with nerve pain?

Official regulatory documents classify Nervobion as a neurotropic vitamin medication. Its primary indication is to assist with the management of neuropathies, which is the medical term for nerve damage or disease that can cause pain, numbness, or tingling. The product is also indicated for preventing and treating deficiencies in Vitamins B1, B6, and B12.


Q: What is the longest period of time people typically use Nervobion?

Regulatory warnings highlight that using high daily dosages for long periods (typically six to twelve months) has been linked to the risk of nerve damage (neuropathy) due to the B6 component. Because of this risk, official documents state that regular professional monitoring is necessary if the product is used over an extended duration.


Q: Does official research cover the use of Nervobion in people over 65?

The studies that inform official product summaries typically focus on adult populations. Research reports that data for specific groups, including the general aging population, remain insufficient to draw broad conclusions about long-term outcomes for individuals over 65. Certainty regarding its effects in these specific populations remains low.


Q: Is Nervobion available over-the-counter or does it always require a prescription?

The regulatory status of Nervobion can vary significantly depending on the country and the formulation. While the higher-concentration injection form is often listed as a Prescription Drug (RX), the oral tablet may be available over-the-counter or classified as a Dietary Supplement in certain regions.


Q: Can people who have had stomach surgery safely use Nervobion?

Official regulatory information notes that conditions which lead to reduced absorption in the stomach or intestines may affect the B12 component of the medication. Official documents indicate that the use of the product requires professional monitoring and assessment for people who have conditions that impact nutrient absorption, such as those who have had stomach surgery.


Q: What does the term 'peripheral neuropathy' mean in the context of Nervobion's use?

Peripheral neuropathy refers to nerve damage outside the brain and spinal cord, causing symptoms like pain, numbness, or muscle weakness. Official product safety constraints note that taking high daily doses of the B6 component over a long period can lead to this type of nerve damage, which may manifest as paresthesia or sensitivity disorders (e.g., tingling).


Q: Is it normal to feel a tingling sensation when first starting Nervobion?

Tingling, medically known as paresthesia, is described in official warnings as a potential sign of peripheral neuropathy, a serious adverse reaction. This reaction is linked to long-term use of high B6 doses, not typically to the short-term or initial use of the medication.


Q: Why might a doctor prescribe Nervobion for a non-nerve-related issue?

The product's overall purpose is to supply essential B1, B6, and B12 cofactors to maintain health and function. Therefore, a doctor might prescribe it for the prevention and treatment of systemic deficiencies in these vitamins, which can manifest with a variety of symptoms beyond just nerve-related complaints.


Q: What does the research say about Nervobion and chronic pain conditions?

Research summarized in official documents has focused primarily on outcomes for patients with Peripheral Neuropathy, specifically observing patterns related to symptom improvement and physical discomfort. The scope of formal, controlled studies for other, broader chronic pain conditions is not explicitly defined in official summaries.


Q: Can taking Nervobion make your urine a different color?

A possible, non-serious side effect that has been reported is chromaturia, which is the medical term for discolored urine, often reddish. According to official product reports, this effect typically resolves on its own within 48 hours of administration.


Q: Is Nervobion suitable for people who follow a vegetarian or vegan diet?

The active ingredient Cyanocobalamin (Vitamin B12) is a key nutrient often sought by those following plant-based diets. However, because official labeling for the different dosage forms also lists various inactive ingredients (excipients), regulatory information advises that the full ingredient list should be reviewed to align with dietary needs.


Q: Does Nervobion interact with common blood pressure medications?

Official documents note that long-term use of certain diuretic medications, such as Loop Diuretics (a type of medication sometimes used for blood pressure or fluid management), is documented to decrease the serum levels of the B1 component. Interactions with other classes of blood pressure medications are not explicitly detailed.


Q: Where can I find the official regulatory information (like the package insert) for Nervobion?

Official product information, such as the complete patient information leaflet or package insert, can often be accessed through government-run medical databases. Examples of these authoritative sources include the NIH's DailyMed or the specific regulatory body websites for your region.


Q: Can Nervobion cause dizziness or affect my ability to drive?

Official product information explicitly states that no known effects of the product on the ability to drive or operate machinery have been established. Furthermore, dizziness is not listed as a frequently reported adverse reaction in regulatory safety summaries.


Q: If I am taking a blood thinner, is Nervobion safe to use?

Official regulatory documents do not list a specific interaction between this product and blood thinners. The product does not contain Vitamin K, which is the component most often associated with an interaction with common anticoagulant medications, such as warfarin.

How should Nervobion be stored and disposed of?

Storage and Disposal of Nervobion

Storage of Nervobion must strictly follow regulatory labeling to ensure product stability.


Official Storage Requirements

Formulation Required Conditions Handling Constraints
Oral Tablets Store below 25 C or 30 C (check specific label). Protect from light and moisture. Keep in the original packaging.
Injection Store in a refrigerator (2 C to 8 C). Do not freeze. Use immediately after opening the ampoule.

All forms must be stored out of the sight and reach of children.


Disposal Instructions

Unused or expired Nervobion must not be discarded in wastewater or sewage. Disposal should follow local regulatory requirements, often utilizing pharmacy take-back programs. Used needles and syringes from the injection form must be placed immediately into a puncture-resistant sharps container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nervobion found in:

A-Z Index: